AMZN
Amazon.com, Inc.
AMZN has the edge over CMG overall, supported by stronger modeled upside and stronger fundamentals.
CMG
Chipotle Mexican Grill, Inc.
CMG offers stronger valuation, but that advantage does not outweigh its weaker overall profile.
AMZN Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Weak | |
| Healthy |
AMZN's revenue, profitability and balance sheet are currently healthy, but its cash flow is weak.
CMG Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Healthy | |
| Strong |
CMG's revenue, profitability, cash flow and balance sheet are all currently healthy.
AMZN PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 22x | $267 | — |
| Forward | 27x | $267 | — |
| Cheap | 34x | $415 | +55% |
| Fair | 60x | $745 | +179% |
| Expensive | 102x | $1,262 | +372% |
Historical ranges are pointers, not guarantees.
AMZN has the edge over CMG in the historical PE scenario, which offers more potential upside but is not a forecast.
CMG PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 28x | $35.17 | — |
| Current | 33x | $35.17 | — |
| Cheap | 37x | $39.28 | +12% |
| Fair | 56x | $59.81 | +70% |
| Expensive | 91x | $97.34 | +177% |
Historical ranges are pointers, not guarantees.
CMG's PE is in its cheap range at 33x. If earnings grow as analysts expect, today's price would be 28x next year's earnings.
AMZN Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Strong growth | |
| Growth | |
| Improving | |
| Moderate | |
| Moderate |
Analysts expect earnings and revenue growth for AMZN, with profitability improving.
CMG Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Improving | |
| Moderate | |
| Low |
CMG has the edge over AMZN on the outlook, with more favorable valuation expectations.
AMZN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $9.87 | -20% |
| Q3 2026 | $12.37 | +75% |
| Q2 2026 | $12.43 | +89% |
| Q1 2026 | $8.36 | +36% |
| Q4 2025 | $7.17 | +30% |
| Q3 2025 | $7.08 | +52% |
| Q2 2025 | $6.56 | +57% |
| Q1 2025 | $6.14 | +72% |
| Q4 2024 | $5.53 | +91% |
AMZN has the edge over CMG on earnings, with more consistent year-over-year improvement.
CMG Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.27 | +19% |
| Q3 2026 | $1.07 | -5.3% |
| Q2 2026 | $1.09 | -2.7% |
| Q1 2026 | $1.09 | -3.5% |
| Q4 2025 | $1.14 | +2.7% |
| Q3 2025 | $1.13 | +5.6% |
| Q2 2025 | $1.12 | +9.8% |
| Q1 2025 | $1.13 | +20% |
| Q4 2024 | $1.11 | +25% |
CMG earned $1.07 per share over the past year, down 5.3% from the year before.
AMZN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $201.9B | +12% |
| Q2 2026 | $200.6B | +20% |
| Q1 2026 | $181.5B | +17% |
| Q4 2025 | $213.4B | +14% |
| Q3 2025 | $180.2B | +13% |
| Q2 2025 | $167.7B | +13% |
| Q1 2025 | $155.7B | +8.6% |
| Q4 2024 | $187.8B | +10% |
AMZN has the edge over CMG on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 14% | +4.2 points |
| Q2 2026 | 14% | +2.3 points |
| Q1 2026 | 13% | +1.3 points |
| Q4 2025 | 12% | +0.4 points |
| Q3 2025 | 9.7% | -1.3 points |
| Q2 2025 | 11% | +1.5 points |
| Q1 2025 | 12% | +1.1 points |
| Q4 2024 | 11% | +3.5 points |
AMZN has the edge over CMG on profitability, with a higher operating margin.
CMG Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $3.3B | +9.6% |
| Q2 2026 | $3.3B | +9.3% |
| Q1 2026 | $3.1B | +7.4% |
| Q4 2025 | $3B | +4.9% |
| Q3 2025 | $3B | +7.5% |
| Q2 2025 | $3.1B | +3% |
| Q1 2025 | $2.9B | +6.4% |
| Q4 2024 | $2.8B | +13% |
CMG's revenue has grown year over year every quarter since late 2020: $3.3B last quarter, up 9.6% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 14% | -2.2 points |
| Q2 2026 | 16% | -2.6 points |
| Q1 2026 | 13% | -3.8 points |
| Q4 2025 | 14% | -0.5 points |
| Q3 2025 | 16% | -1.1 points |
| Q2 2025 | 18% | -1.5 points |
| Q1 2025 | 17% | +0.3 points |
| Q4 2024 | 15% | +0.2 points |
CMG's operating margin was 14% last quarter, down 2.2 points from the same quarter a year ago.
AMZN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$34.8B | -8202% |
| Q2 2026 | -$8.8B | -2757% |
| Q1 2026 | -$18.2B | -$10.2B |
| Q4 2025 | $14.9B | -16% |
| Q3 2025 | $430M | -87% |
| Q2 2025 | $332M | -96% |
| Q1 2025 | -$8B | -297% |
| Q4 2024 | $17.8B | -36% |
AMZN's free cash flow was −$46.9B over the past year, against $10.6B the year before.
CMG Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $347.1M | -15% |
| Q2 2026 | $463.4M | +16% |
| Q1 2026 | $471M | +14% |
| Q4 2025 | $228.4M | -35% |
| Q3 2025 | $406.2M | +36% |
| Q2 2025 | $400.7M | -5.1% |
| Q1 2025 | $412.3M | -5.6% |
| Q4 2024 | $353.9M | +278% |
CMG has the edge over AMZN on cash generation, producing positive trailing cash flow while its opponent burns cash.
AMZN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +26M shares |
| 1 year | +0.8% | +84M shares |
| 3 years | +3.5% | +371M shares |
| 5 years | +6.1% | +629M shares |
| Available history | +8.2% | +829M shares |
AMZN has 10.9B diluted shares, up 0.8% from a year ago.
| Quarter | Spent |
|---|---|
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
| Q1 2023 | — |
| Q4 2022 | — |
| Q3 2022 | — |
| Q2 2022 | $3.3B |
CMG Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.9% | -11.4M shares |
| 1 year | -5.4% | -71.8M shares |
| 3 years | -8.4% | -116M shares |
| 5 years | -11% | -156M shares |
| Available history | -10% | -147M shares |
CMG has the edge over AMZN on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $110M |
| Q2 2026 | $653.9M |
| Q1 2026 | $701M |
| Q4 2025 | $741.8M |
| Q3 2025 | $686.7M |
| Q2 2025 | $443.3M |
| Q1 2025 | $553.8M |
| Q4 2024 | $339M |
CMG spent $2.2B buying back its own shares over the past year, up 9.1% from the year before.
AMZN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.7x | Very low |
| Q2 2026 | 0.3x | Very low |
| Q1 2026 | 0.1x | Very low |
| Q4 2025 | -0.1x | Net Cash |
| Q3 2025 | -0.1x | Net Cash |
| Q2 2025 | -0.0x | Net Cash |
| Q1 2025 | -0.1x | Net Cash |
| Q4 2024 | -0.2x | Net Cash |
AMZN's net debt is less than a year of its operating earnings (EBITDA), after holding more cash than debt a year ago.
CMG Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.3x | Net Cash |
| Q2 2026 | -0.1x | Net Cash |
| Q1 2026 | -0.1x | Net Cash |
| Q4 2025 | -0.2x | Net Cash |
| Q3 2025 | -0.3x | Net Cash |
| Q2 2025 | -0.4x | Net Cash |
| Q1 2025 | -0.3x | Net Cash |
| Q4 2024 | -0.3x | Net Cash |
CMG has the edge over AMZN on leverage, with a lower net debt burden relative to earnings.
AMZN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 57.1 | Neutral |
| Stochastic | 50.0 | Neutral |
AMZN's weekly RSI is 57 (neutral) and its Stochastic is 50 (neutral).
CMG Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 53.1 | Neutral |
| Stochastic | 56.0 | Neutral |
CMG's weekly RSI is 53 (neutral) and its Stochastic is 56 (neutral).
AMZN PE vs Consumer Cyclical Sector
| Metric | AMZN | Sector median | Relative |
|---|---|---|---|
| PE | 22x | 18x | 20% above |
| PE % | 4 | 47 | 43 pts below |
AMZN has the edge over CMG on valuation relative to its sector.
CMG PE vs Consumer Cyclical Sector
| Metric | CMG | Sector median | Relative |
|---|---|---|---|
| PE | 33x | 18x | 82% above |
| PE % | 11 | 47 | 36 pts below |
CMG is trading at 33x earnings, a 82% premium to the Consumer Cyclical sector's median of 18x.
AMZN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $253.6 | 5.5% above |
| 20 week MA | $254.9 | 4.9% above |
| 50 week MA | $242.5 | 10% above |
| 100 week MA | $229.6 | 17% above |
| 200 week MA | $191.4 | 40% above |
AMZN has the edge over CMG on trend strength, trading above more of its moving averages.
CMG Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $31.8 | 11% above |
| 20 week MA | $33.8 | 4.1% above |
| 50 week MA | $34.6 | 1.7% above |
| 100 week MA | $41.3 | 15% below |
| 200 week MA | $44.6 | 21% below |
CMG has bounced recently, but its long-term trend is still down: it's above its 8-, 20- and 50-week averages, but 21% below its 200-week average.
AMZN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $93.5 | $158.6 | +70% |
| 2021 | $158.6 | $171.1 | +7.8% |
| 2022 | $171.1 | $85.3 | -50% |
| 2023 | $85.3 | $151.9 | +78% |
| 2024 | $151.9 | $223.8 | +47% |
| 2025 | $223.8 | $232.5 | +3.9% |
| 2026 YTD | $232.5 | $267.4 | +15% |
AMZN has the edge over CMG on returns for 2026, with the stronger performance.
CMG Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $16.7 | $28.3 | +69% |
| 2021 | $28.3 | $35.0 | +24% |
| 2022 | $35.0 | $28.3 | -19% |
| 2023 | $28.3 | $45.7 | +62% |
| 2024 | $45.7 | $60.8 | +33% |
| 2025 | $60.8 | $37.8 | -38% |
| 2026 YTD | $37.8 | $35.2 | -7% |
CMG has finished higher in four of the last six years, two of them by more than 50%. It's down 7% so far in 2026.